Cormedix(DE:19KA)
€4.23+0.22 (+5.53%)
DE:19KA
Cormedix earnings date
€4.23
At close:+0.22 (+5.53%)
Cormedix (19KA) Q2 2021 Earnings Report
2 Followers
DE:19KA Q2 2021 EPS Results
- Actual EPS
- -EUR 0.11
- Consensus EPS
- -EUR 0.16
- Beat/Miss
- Beat by +EUR 0.05
- One Year Ago EPS
- -EUR 0.13
DE:19KA Q2 2021 Revenue Results
- Actual Revenue
- EUR 7,466.755
- Expected Revenue
- EUR 39.20K
- Beat/Miss
- Missed by -EUR 31.73K
- YoY Revenue Growth
- -50.19%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/12/2021
- Time
- After Close
- Conference Call
- Thursday, August 12, 2021
DE:19KA Upcoming Earnings
Cormedix's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:19KA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | -0.14- | 0.15 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.11-0.17 | 1.15 | -115.08% (-1.32) | |
| Aug 13, 2026 | 2026 (Q2) | 0.220.26 | 0.26 | 0.00% (+0.00) | |
| May 14, 2026 | 2026 (Q1) | 0.310.39 | 0.27 | 43.33% (+0.12) | |
| Mar 05, 2026 | 2025 (Q4) | 0.740.15 | 0.2 | -27.27% (-0.05) | |
| Nov 12, 2025 | 2025 (Q3) | 0.581.15 | -0.05 | 2620.00% (+1.19) | |
| Aug 07, 2025 | 2025 (Q2) | 0.170.26 | -0.23 | 216.00% (+0.49) | |
| May 06, 2025 | 2025 (Q1) | 0.240.27 | -0.23 | 220.00% (+0.50) | |
| Mar 25, 2025 | 2024 (Q4) | 0.120.20 | -0.24 | 184.62% (+0.44) | |
| Oct 30, 2024 | 2024 (Q3) | -0.11-0.05 | -0.15 | 70.59% (+0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

